Metoclopramide IV/IM Dosing for a 12-Year-Old
For a 12-year-old child, administer metoclopramide 10 mg IV slowly over 1-2 minutes or IM, which can be repeated every 6-8 hours as needed, with a maximum daily dose not exceeding 30-40 mg. 1
Dose Calculation and Administration
Standard Dosing
- Weight-based dosing: 0.1 mg/kg per dose is the recommended pediatric calculation 1
- Fixed dose for age 12: Since children ≥14 years receive the adult dose of 10 mg, and children 6-14 years receive 2.5-5 mg for certain indications, a 12-year-old typically receives 10 mg per dose for most therapeutic uses 1
- Route: Can be given either IV (slowly over 1-2 minutes) or IM 1
Frequency and Maximum Dosing
- Frequency: Every 6-8 hours as needed 2
- Maximum: Do not exceed 3-4 doses per day (30-40 mg total daily dose) to minimize risk of extrapyramidal reactions 3
- Duration: Parenteral metoclopramide should be limited to 1-2 days of use 1
Critical Safety Considerations
Extrapyramidal Reaction Risk
- Children and adolescents are at significantly higher risk for acute extrapyramidal reactions (EPRs) compared to older adults, with rates of 15-33% reported at higher doses 3
- Prophylactic diphenhydramine (25-50 mg IV or IM) should be strongly considered when administering metoclopramide to reduce EPR risk 3
- If acute dystonic reactions occur, immediately inject 50 mg diphenhydramine IM, and symptoms usually subside 1
Administration Technique
- IV route: Must be given slowly over 1-2 minutes to reduce side effects 1
- Never give as rapid IV push, as this increases risk of adverse reactions 1
- For doses requiring dilution (>10 mg), use 50 mL of normal saline and infuse over at least 15 minutes 1
Common Pitfalls to Avoid
Duration of Use
- Do not use for more than 1-2 days parenterally 1
- Prolonged use significantly increases risk of tardive dyskinesia and other movement disorders 4
- Even short-term, low-dose use has been associated with long-lasting adverse effects in young patients 4
Consecutive Day Dosing
- Children receiving metoclopramide on consecutive days have higher frequency of EPRs 3
- If multi-day treatment is necessary, consider alternative antiemetics or transition to oral route after initial parenteral dose 1
Monitoring Requirements
- Watch for restlessness, drowsiness, akathisia (motor restlessness), and involuntary movements 3, 5
- Monitor for dystonic reactions (muscle spasms, particularly of neck and face) which require immediate treatment 1
- Symptoms may include twitches, jerks, tremors of eyelids, tongue, neck, fingers, arms and legs 4
Indication-Specific Dosing
For Severe Nausea/Vomiting
For Chemotherapy-Induced Emesis (if applicable)
- Higher doses (1-2 mg/kg) have been studied but carry substantially higher risk of EPRs (15-33%) 3
- Not recommended without specialist consultation and mandatory diphenhydramine co-administration 3